| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5947361 | Atherosclerosis | 2013 | 7 Pages |
Abstract
The addition of the new oral anticoagulants on top of standard therapy in the setting of ACS results in an excessive risk of major bleedings without any clear evidence of outweighing clinical benefits.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Karolina Obonska, Eliano Pio Navarese, Alexandra Lansky, Giuseppe Tarantini, Roberta Rossini, Marek Kozinski, Giuseppe Musumeci, Giuseppe Di Pasquale, Bartosz Górny, Anna Szczesniak, Mariusz Kowalewski, Paul Alfred Gurbel, Jacek Kubica,